Q3 FY2026 · ended Sep 30, 2026 · Revenue $14.03M, +9.0% YoY · Filed Nov 5, 2026
Apyx Medical Corp (APYX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In Q3 of fiscal 2026, the quarter ended Sep 30, 2026, it reported revenue of $14.0 million and a net loss of $1.8 million. Free cash flow was -$1.9 million. As of Sep 30, 2026 it held $25.8 million in cash and investments and $41.7 million in total debt.
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- APYX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Clearwater, FL
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 719135
- Former names
- BOVIE MEDICAL CORP (until Jan 2, 2019); BOVIE MEDICAL Corp (until Jan 2, 2019); AN CON GENETICS INC (until Jan 13, 1999)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q3 FY2026 Sep 30, 2026 |
Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $14.0M | $13.9M | $12.5M | $19.2M | $12.9M |
| Operating income | -$571,000 | -$1.8M | -$911,000 | $11,000 | -$832,000 |
| Net income | -$1.8M | -$3.2M | -$2.1M | -$1.3M | -$2.0M |
| Operating cash flow | -$1.6M | -$3.5M | -$572,000 | -$2.5M | -$3.5M |
| Free cash flow | -$1.9M | -$3.6M | -$632,000 | -$2.8M | -$4.1M |
| Total assets | $61.7M | $61.1M | $63.0M | $66.8M | $57.4M |
| Total liabilities | $51.6M | $50.0M | $49.9M | $52.0M | $51.3M |
| Stockholders' equity | $9.6M | $10.7M | $12.8M | $14.5M | $5.8M |
| Cash and investments | $25.8M | $27.6M | $31.1M | $31.7M | $25.1M |
| Total debt | $41.7M | $41.8M | $41.9M | $42.0M | $42.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 8-K |
Current report
Other events
|
Sep 29, 2026 | Sep 29, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 7, 2026 | Aug 6, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
All 992 Apyx Medical Corp SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.